237 related articles for article (PubMed ID: 2738153)
1. Anti-peripheral nerve myelin antibodies in Guillain-Barre syndrome bind a neutral glycolipid of peripheral myelin and cross-react with Forssman antigen.
Koski CL; Chou DK; Jungalwala FB
J Clin Invest; 1989 Jul; 84(1):280-7. PubMed ID: 2738153
[TBL] [Abstract][Full Text] [Related]
2. Characterization of complement-fixing antibodies to peripheral nerve myelin in Guillain-Barré syndrome.
Koski CL
Ann Neurol; 1990; 27 Suppl():S44-7. PubMed ID: 2194426
[TBL] [Abstract][Full Text] [Related]
3. Anti-peripheral myelin antibody in patients with demyelinating neuropathy: quantitative and kinetic determination of serum antibody by complement component 1 fixation.
Koski CL; Humphrey R; Shin ML
Proc Natl Acad Sci U S A; 1985 Feb; 82(3):905-9. PubMed ID: 3856240
[TBL] [Abstract][Full Text] [Related]
4. Search for antibodies to neutral glycolipids in sera of patients with Guillain-Barré syndrome.
Ilyas AA; Mithen FA; Chen ZW; Cook SD
J Neurol Sci; 1991 Mar; 102(1):67-75. PubMed ID: 1856733
[TBL] [Abstract][Full Text] [Related]
5. Activation of terminal components of complement in patients with Guillain-Barré syndrome and other demyelinating neuropathies.
Koski CL; Sanders ME; Swoveland PT; Lawley TJ; Shin ML; Frank MM; Joiner KA
J Clin Invest; 1987 Nov; 80(5):1492-7. PubMed ID: 3680509
[TBL] [Abstract][Full Text] [Related]
6. Clinical correlation with anti-peripheral-nerve myelin antibodies in Guillain-Barré syndrome.
Koski CL; Gratz E; Sutherland J; Mayer RF
Ann Neurol; 1986 Jun; 19(6):573-7. PubMed ID: 3729311
[TBL] [Abstract][Full Text] [Related]
7. Antibodies in sera from patients with inflammatory demyelinating polyradiculoneuropathy react with ganglioside LM1 and sulphatide of peripheral nerve myelin.
Fredman P; Vedeler CA; Nyland H; Aarli JA; Svennerholm L
J Neurol; 1991 Apr; 238(2):75-9. PubMed ID: 1856740
[TBL] [Abstract][Full Text] [Related]
8. Electrophysiologic studies in the Guillain-Barré syndrome: effects of plasma exchange and antibody rebound.
Rudnicki S; Vriesendorp F; Koski CL; Mayer RF
Muscle Nerve; 1992 Jan; 15(1):57-62. PubMed ID: 1732763
[TBL] [Abstract][Full Text] [Related]
9. Plasma exchange in Guillain-Barré syndrome: effect on anti-peripheral nerve myelin antibodies.
Vedeler CA; Nyland H
Acta Neurol Scand; 1990 Aug; 82(2):147-9. PubMed ID: 2256446
[TBL] [Abstract][Full Text] [Related]
10. Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barré syndrome and controls: correlation and prognosis.
Vriesendorp FJ; Mishu B; Blaser MJ; Koski CL
Ann Neurol; 1993 Aug; 34(2):130-5. PubMed ID: 8338337
[TBL] [Abstract][Full Text] [Related]
11. [Monoclonal IgM autoantibody activity vis-à-vis glycoconjugates of peripheral nerves: apropos of 112 cases].
Caudie C; Vial C; Petiot P; Bancel J; Lombard C; Gonnaud PM
Ann Biol Clin (Paris); 2001; 59(5):567-77. PubMed ID: 11602387
[TBL] [Abstract][Full Text] [Related]
12. Class and IgG subclass distribution of antibodies against peripheral nerve myelin in sera from patients with inflammatory demyelinating polyradiculoneuropathy.
Vedeler CA; Matre R; Nyland H
Acta Neurol Scand; 1988 Nov; 78(5):401-7. PubMed ID: 2464267
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to acidic glycolipids in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
Ilyas AA; Mithen FA; Dalakas MC; Chen ZW; Cook SD
J Neurol Sci; 1992 Jan; 107(1):111-21. PubMed ID: 1578228
[TBL] [Abstract][Full Text] [Related]
14. Serum antibodies to gangliosides in Guillain-Barré syndrome.
Ilyas AA; Willison HJ; Quarles RH; Jungalwala FB; Cornblath DR; Trapp BD; Griffin DE; Griffin JW; McKhann GM
Ann Neurol; 1988 May; 23(5):440-7. PubMed ID: 3133978
[TBL] [Abstract][Full Text] [Related]
15. Macrophage procoagulant activity as a measure of cell-mediated immunity to P2 protein of peripheral nerves in the Guillain-Barré syndrome.
Geczy C; Raper R; Roberts IM; Meyer P; Bernard CC
J Neuroimmunol; 1985 Aug; 9(3-4):179-91. PubMed ID: 2410449
[TBL] [Abstract][Full Text] [Related]
16. Antibodies to peripheral nerve myelin may occur without clinical neuropathy in healthy persons.
Vrethem M; Skogh T; Berlin G; Holmgren H; Ernerudh J
J Neuroimmunol; 1991 Jun; 32(3):219-22. PubMed ID: 1851766
[TBL] [Abstract][Full Text] [Related]
17. Mouse monoclonal and rabbit polyclonal antibodies prepared to human myelin-associated glycoprotein also react with glycosphingolipids of peripheral nerve.
Ilyas AA; Dobersen MJ; Willison HJ; Quarles RH
J Neuroimmunol; 1986 Aug; 12(2):99-106. PubMed ID: 2426302
[TBL] [Abstract][Full Text] [Related]
18. Sulfated glucuronyl glycolipids reacting with anti-myelin-associated glycoprotein monoclonal antibodies including IgM paraproteins in neuropathy: species distribution and partial characterization of epitopes.
Ilyas AA; Dalakas MC; Brady RO; Quarles RH
Brain Res; 1986 Oct; 385(1):1-9. PubMed ID: 2429733
[TBL] [Abstract][Full Text] [Related]
19. Complement-fixing antiperipheral myelin antibodies and C9 neoantigen in serum of patients with Guillain-Barré syndrome: quantitation, kinetics, and clinical correlation.
Koski CL
Ann N Y Acad Sci; 1987; 505():319-25. PubMed ID: 3479928
[No Abstract] [Full Text] [Related]
20. Kinetics of anti-peripheral nerve myelin antibody in patients with Guillain-Barré syndrome treated and not treated with plasmapheresis.
Vriesendorp FJ; Mayer RF; Koski CL
Arch Neurol; 1991 Aug; 48(8):858-61. PubMed ID: 1898263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
